Liposomal Curcumin: What It Is and How It Compares to Other Forms
You may have heard that curcumin is poorly absorbed. This is true—and it is the central challenge of all curcumin supplementation. But it is also a solvable problem. In the last two decades, supplement manufacturers and pharmaceutical researchers have developed multiple enhanced delivery systems that dramatically increase how much curcumin actually reaches your tissues.
Liposomal curcumin is one of these systems. Here is a clear, evidence-based breakdown of how it works, how it compares to other forms, and how to choose the right one.
Why Standard Curcumin Has a Bioavailability Problem
Curcumin is poorly water-soluble and rapidly metabolized in the gut and liver before it can reach the bloodstream. The landmark study by Shoba and colleagues, published in Planta Medica (1998), quantified this problem: in human volunteers, only a negligible amount of curcumin was detectable in blood after oral ingestion of standard curcumin powder. The same study found that adding 20 mg of piperine (black pepper extract) to 2,000 mg curcumin increased bioavailability by 2,000%—demonstrating how dramatically delivery technology can change outcomes.
This finding launched an entire field of curcumin bioavailability research and drove the development of multiple enhanced delivery systems.
What Is Liposomal Curcumin?
Liposomes are tiny spherical vesicles made of phospholipid bilayers—the same material that forms cell membranes. When curcumin is encased inside liposomes, several things happen:
- The lipid shell protects curcumin from degradation in the gut
- Liposomes fuse easily with cell membranes, improving intracellular delivery
- The hydrophilic exterior allows curcumin to dissolve in water (overcoming its solubility problem)
- Liver first-pass metabolism is partially bypassed
The result is significantly higher plasma curcumin levels compared to standard curcumin powder.
Comparison of All Enhanced Curcumin Forms
| Form | Technology | Bioavailability vs. Standard | Key Evidence |
|---|---|---|---|
| Standard curcumin + piperine | CYP enzyme inhibition | ~20x | Shoba et al., 1998 |
| Meriva (phytosome) | Phosphatidylcholine complex | ~29x | Marczylo et al., 2007 |
| BCM-95 (Biocurcumax) | Turmeric essential oils | ~7x | Antony et al., 2008 |
| Longvida (SLCP) | Solid lipid nanoparticles | Up to 65x (plasma free curcumin) | Gota et al., 2010 |
| Theracurmin | Ultra-fine colloidal dispersion | ~27x | Sasaki et al., 2011 |
| Liposomal curcumin | Phospholipid bilayer encapsulation | Significantly higher (varies by formulation) | Multiple studies |
Which Form Has the Best Clinical Evidence?
Longvida (SLCP Technology)
Longvida uses solid lipid curcumin particle (SLCP) technology developed at UCLA. A pharmacokinetic study by Gota et al. (2010) found Longvida produced 65 times more free curcumin in plasma compared to standard curcumin in human volunteers. Free curcumin (not conjugated/metabolized) is the form that crosses the blood-brain barrier—making Longvida particularly relevant for brain applications.
The Small et al. (2018) UCLA study that showed memory improvement and reduced amyloid accumulation over 18 months used Longvida curcumin.
Meriva (Phytosome)
Meriva binds curcumin to phosphatidylcholine from sunflower or soy lecithin. A study by Marczylo et al. (2007) found Meriva produced 29-fold higher plasma curcumin levels than standard extract in human subjects. Meriva has been used in multiple clinical trials for osteoarthritis with good results and is piperine-free (beneficial for people who need to avoid black pepper).
Theracurmin
Theracurmin uses ultra-fine particle size and natural surfactants to create a colloidal dispersion. A Japanese study by Sasaki et al. (2011) found it produced 27-fold greater AUC (area under the curve) than standard curcumin. Theracurmin has been used in cardiovascular and cancer-supportive research.
Does the Form Matter for Specific Conditions?
For most inflammatory conditions, any of the above forms significantly outperforms standard curcumin. For brain applications specifically, forms that deliver free (unconjugated) curcumin—particularly Longvida—may offer additional benefit because conjugated curcumin does not cross the blood-brain barrier as effectively.
For joint conditions, phytosome forms (Meriva) have the most clinical trial data specifically in osteoarthritis populations.
What to Look For on the Label
- Named technology: Longvida, Meriva, BCM-95, Theracurmin, or liposomal—not just “enhanced bioavailability”
- Curcumin mg, not just turmeric mg: “500 mg turmeric root” means 10–25 mg curcumin; you need the curcumin content specified
- Third-party testing: Certificate of Analysis for potency and purity
- No proprietary blends hiding doses: You should know exactly what you are getting
Curcumitol-Q by Advanced Bionutritionals is developed by physicians with a focus on enhanced curcumin bioavailability and clinical-grade formulation standards. It represents the approach of prioritizing how much curcumin actually reaches your tissues, not just what is in the capsule.
Frequently Asked Questions
Is liposomal curcumin better than regular curcumin?
Yes, significantly. Standard curcumin without bioavailability enhancement has less than 1% oral bioavailability. Liposomal and other enhanced forms deliver dramatically more curcumin to the bloodstream. For therapeutic purposes, enhanced forms are not just “better”—they are often the difference between a therapeutic dose reaching your tissues versus almost none at all.
What is the difference between liposomal and phytosome curcumin?
Liposomal curcumin encases curcumin in phospholipid spheres (like tiny bubbles). Phytosome (like Meriva) chemically bonds curcumin to phosphatidylcholine. Both significantly improve absorption, but through different mechanisms. Phytosome has more clinical trial data specifically for arthritis; liposomal is a well-established delivery technology borrowed from pharmaceutical drug delivery.
Can I make liposomal curcumin at home?
DIY liposomal formulations using lecithin and ultrasonic methods produce inconsistent particle sizes and uncertain bioavailability. The precise particle size and stability of commercial liposomal supplements requires pharmaceutical manufacturing equipment. Home preparations are unlikely to match the bioavailability of quality commercial products.
How does liposomal curcumin compare to curcumin with piperine?
Piperine increases curcumin bioavailability approximately 20-fold by inhibiting liver metabolism enzymes. This is significant but also affects the metabolism of other drugs. Liposomal and phytosome forms achieve comparable or greater bioavailability without the drug interaction risk of piperine—making them preferable for people on multiple medications.
How long does it take for liposomal curcumin to work?
Peak plasma levels occur 1–2 hours after ingestion of most enhanced curcumin forms. Sustained anti-inflammatory effects (reduced CRP, joint pain improvement) develop over 4–8 weeks of consistent daily use. The faster absorption does not mean faster symptom resolution—curcumin’s anti-inflammatory mechanism requires sustained pathway modulation.
Sources
- Shoba G, et al. “Influence of Piperine on the Pharmacokinetics of Curcumin.” Planta Medica, 1998.
- Marczylo TH, et al. “Comparison of Systemic Availability of Curcumin with That of Curcumin Formulated with Phosphatidylcholine.” Cancer Chemotherapy and Pharmacology, 2007.
- Gota VS, et al. “Safety and Pharmacokinetics of a Solid Lipid Curcumin Particle Formulation in Osteosarcoma Patients.” Journal of Agricultural and Food Chemistry, 2010.
- Small GW, et al. “Memory and Brain Amyloid Effects of Bioavailable Curcumin.” Am J Geriatric Psychiatry, 2018.
- Antony B, et al. “A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95.” Indian Journal of Pharmaceutical Sciences, 2008.
